FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Immunotherapy after surgery is good for patients with advanced cancer

2.

Significant differences in breast cancer care still exist, but surgeons can change.

3.

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

4.

Even when they are not paying attention, children are still learning.

5.

Breast awareness: What to look for in your self-exam


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot